Cyproterone acetate–-mechanism of action and clinical effectiveness in prostate cancer treatment
- 15 December 1993
- Vol. 72 (S12) , 3810-3815
- https://doi.org/10.1002/1097-0142(19931215)72:12+<3810::aid-cncr2820721710>3.0.co;2-o
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Androgens and androgen-receptors in prostate tissue from patients with benign prostatic hyperplasia: Effects of cyproterone acetateThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Orchidectomy versus buserelin in combination with cyproterone acetate, for 2 weeks or continuously, in the treatment of metastatic prostatic cancer. Preliminary results of EORTC-trial 30843The Journal of Steroid Biochemistry and Molecular Biology, 1990
- A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgensBiochemical and Biophysical Research Communications, 1990
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Effects of androgen and antiandrogen on growth, morphology and synthesis of specific proteins in mouse mammary carcinoma cellsJournal of Steroid Biochemistry, 1988
- Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in cultureThe Journal of Steroid Biochemistry and Molecular Biology, 1988
- Intratissular androgens in benign prostatic hyperplasia and prostatic cancerJournal of Steroid Biochemistry, 1986
- Receptor binding and biological activity of steroidal and nonsteroidal antiandrogensJournal of Steroid Biochemistry, 1981
- Treatment of Advanced Prostatic Cancer with Parenteral Cyproterone Acetate: A Phase III Randomised Trial*British Journal of Urology, 1980
- THE STIMULATION OF MALE DUCT DERIVATIVES IN FEMALE GUINEA-PIGS WITH AN ANTIANDROGEN, CYPROTERONE ACETATEReproduction, 1974